Indeed, we observed enhanced γH2AX and Ku70 staining as well as weakened BRCA1 staining in the SPOP-mutated PCa, suggesting genomic instability in SPOP-mutated PCa and potential sensitivity to PARP inhibitors. The gene discussed is XRCC6; the disease is posterior cortical atrophy.